IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSSI, Aroldo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.322
EU - Europa 1.057
AS - Asia 358
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
SA - Sud America 1
Totale 2.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.318
UA - Ucraina 278
IE - Irlanda 207
SE - Svezia 181
SG - Singapore 140
IT - Italia 116
HK - Hong Kong 86
DE - Germania 70
FI - Finlandia 66
RU - Federazione Russa 56
CN - Cina 50
VN - Vietnam 49
GB - Regno Unito 31
FR - Francia 17
KR - Corea 16
BE - Belgio 12
TR - Turchia 10
CH - Svizzera 6
CZ - Repubblica Ceca 6
PL - Polonia 5
UZ - Uzbekistan 5
CA - Canada 3
ES - Italia 2
EU - Europa 2
LB - Libano 2
NL - Olanda 2
AR - Argentina 1
IS - Islanda 1
MX - Messico 1
RO - Romania 1
TN - Tunisia 1
Totale 2.741
Salva come PNG Salva come JPEG
Città #
Chandler 264
Dublin 207
Jacksonville 154
San Mateo 134
Singapore 105
Boardman 103
Hong Kong 86
Ann Arbor 68
Santa Clara 55
Medford 53
Princeton 53
Dong Ket 49
Altamura 42
Ashburn 41
Wilmington 38
Lawrence 31
Beijing 26
Perugia 26
Andover 23
Des Moines 21
Saint Petersburg 20
Seoul 15
Woodbridge 14
Helsinki 13
Brussels 12
Izmir 10
Munich 10
Norwalk 7
San Paolo di Civitate 7
Brno 6
Auburn Hills 5
Bari 5
Los Angeles 5
Frankfurt Am Main 4
Moscow 4
New York 4
Rome 4
Shanghai 4
Marrùbiu 3
Montemesola 3
Ottawa 3
Trieste 3
Den Haag 2
Foligno 2
Madrid 2
Milan 2
Redmond 2
San Diego 2
Centrale 1
Chicago 1
Dallas 1
Frankfurt am Main 1
Fremont 1
Genova 1
Geumjeong-gu 1
Guangzhou 1
Houston 1
Isidro Casanova 1
Kiev 1
London 1
Marseille 1
Mexico City 1
Modena 1
Nanning 1
Paris 1
Philadelphia 1
Piossasco 1
Redwood City 1
Reykjavik 1
San Giuliano Milanese 1
Stella Cilento 1
Tappahannock 1
Terni 1
Totale 1.777
Salva come PNG Salva come JPEG
Nome #
Botulinum toxin versus lidocaine in the treatment of myofacial pain: a double blind randomized study 93
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 90
A multidiscilinary method for a successful aging 88
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 83
Disturbi dell'equilibrio nei pazienti con cefalea primaria: entità reale o soggettiva? Valutazione qualitativa e quantitativa mediante stabilometria statica - Atti XVI Conresso Nazionale "Cefalee ed età della vita" 79
Neurobiotica: studio multidisciplinare per il recupero delle funzioni cerebrali 78
Tossina botulinica: nuove possibilità di impiego 74
Acute dystonia induced by the combination of midodrine and perphenazine. 72
A unique association of Marfan syndrome with craniofacial hypoplasia, oligophrenia and severe microphthalmia. 71
Clinical aspects and management of levodopa-induced dyskinesia. 70
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 69
Balance disorders in headache patients: evaluation by computerized static stabilometry 67
Demenza e pseudodemenza: utilità dei criteri diagnostici 65
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 65
Creatine kinase BB activity in serum of patients with acute stroke: correlation with the severity of brain damage. 62
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 61
Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder. 60
A magnetization transfer study of mild and advanced Parkinson's disease. 60
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. 57
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 56
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 56
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 53
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 52
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 52
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease 52
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. 49
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 49
Modificazioni del nervo sciatico nel ratto indotte da diete lipidiche. 47
Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. 47
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 47
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 46
A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline 45
Multimodal use of computed tomography in early acute stroke 44
The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. 44
CSF Biomarkers in Parkinson's disease 43
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study 42
The Brain Dopaminergic System and Hyperthermia: The Neuroleptic Malignant Syndrome and The Parkinsonism-hyperpyrexia Syndrome 42
Hot water epilepsy and Mccune-Albright syndrome: a case report. 42
Botulinum A toxin intravesical injection in patients with Parkinson’ s disease and Multiple System Atrophy with overactive bladder syndrome and detrusor overactivity. 42
Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease. 41
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. 41
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 41
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 40
The endocannabinoid system in Parkinson's disease. 40
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed atrofia multi- sistemica. 39
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease. 38
Tappe dello sviluppo cerebrale in relazione alla disponibilità di nutrienti a partire dall'australopiteco 38
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 36
Il trattamento della sclerosi multipla 35
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 34
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 30
Iodine- Iodine-123-N-omega-fluoropropyl fluoropropyl fluoropropyl-2beta-carbomethoxy carbomethoxy carbomethoxy-3beta-(4- iodophenyl)- iodophenyl)-nortropane nortropane nortropane brain SPET with brain SPET with brain SPET with semiquantitative analysis in semiquantitative analysis in Parkinson’s disease as evaluated by support vector machine classifier: diagnostic performance and influence of age diagnostic performance and influence of age 30
Disturbi dell'equilibrio in pazienti con mcefalea: diversi meccanismi patogenetici? 29
Totale 2.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020188 0 0 0 0 41 2 44 4 46 26 4 21
2020/2021546 5 42 22 45 147 34 42 2 72 21 56 58
2021/2022428 13 95 12 28 14 1 2 134 4 9 51 65
2022/2023787 59 145 14 71 68 84 0 33 277 3 23 10
2023/2024313 23 22 17 10 2 4 46 14 53 7 49 66
2024/2025259 18 72 26 49 94 0 0 0 0 0 0 0
Totale 2.826